Free shipping on all orders over $ 500

 About 1 result found for searched term "2238831-60-0" (0.089 seconds)

Cat.No.  Name Target
M40765 Datopotamab deruxtecan Antibody-Drug Conjugates (ADCs)
Dato-DXd; DS-1062
Datopotamab deruxtecan is an antibody-coupled drug (ADC) consisting of a humanized, monoclonal antibody targeting human trophoblast cell surface glycoprotein antigen 2 (Trop2) conjugated to an innovative DNA topoisomerase I inhibitor (DXd) for use in studies related to non-small cell lung cancer (NSCLC).



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.